Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170624034726N2Phase 3Completed
Phase 3, randomised, double-blind trial comparing Remifentanil + propofol maintenance with Propofol maintenance control (2 arms). Primary endpoint: Recovery condition. Started Apr 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170624034726N2.